Why A Vaccine Won’t Be a Quick Fix for COVID-19

Tedros Adhanom Ghebreyesus, director-basic, Environment Wellbeing Firm, Geneva, Switzerland. Barry Bloom, PhD, Joan L. and…

Tedros Adhanom Ghebreyesus, director-basic, Environment Wellbeing Firm, Geneva, Switzerland.

Barry Bloom, PhD, Joan L. and Julius H. Jacobson investigation professor of community wellbeing, T.H. Chan College of General public Wellbeing, Harvard University, Cambridge, MA.

Robert Litan, PhD, JD, nonresident senior fellow, economic reports, the Brookings Institute, Washington, D.C.

Gregory Poland, MD, professor of medication, internist, Mayo Clinic, Rochester, MN.

Countrywide Academies Push: “Discussion Draft of the Preliminary Framework for Equitable Allocation of a COVID-19 Vaccine,” Sept. 1, 2020.

Environment Wellbeing Firm: “Draft Landscape of COVID-19 Prospect Vaccines,” accessed Sept. 1, 2020.

U.S. Office of Wellbeing and Human Providers: “Explaining Procedure Warp Speed,” accessed, Sept. 1, 2020.

U.S. Federal government Accountability Workplace: “Herd Immunity for COVID-19,” July 7, 2020.

Gallup Poll: “One in Three Us citizens Would not get COVID-19 Vaccine,” Aug. 7, 2020.

Information Launch, Food and drug administration, June 30, 2020.

The Lancet: “COVID-19 vaccine trials need to seek out worthwhile efficacy.”